EFFECT OF INTERMITTENT DOSING REGIMENS OF ERLOTINIB ON METHYLNITROSOUREA-INDUCED MAMMARY CARCINOGENESIS

EGFR inhibitors are employed in therapy of lung and pancreatic cancers, and effectively prevent cancers in multiple animal models. Although daily dosing with erlotinib is effective, weekly dosing may reduce toxicity and have advantages, particularly for prevention. We tested alternative dosing regim...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lubet, Ronald A., Szabo, Eva, Iwata, Kenneth K., Gill, Stanley C., Tucker, Chris, Bode, Ann, Steele, Vernon E., Juliana, M. Margaret, Nicastro, Holly L., Grubbs, Clinton J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3813957/
https://ncbi.nlm.nih.gov/pubmed/23531447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-12-0322
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia